Fabtech Technologies Limited (NSE:FABTECH)
135.67
-3.09 (-2.23%)
At close: Nov 9, 2026
Fabtech Technologies Revenue
Fabtech Technologies had revenue of 749.84M INR in the quarter ending June 30, 2026, with 10.26% growth. This brings the company's total for the last twelve months to 4.18B, up 14.16% year-over-year. In the fiscal year ending March 31, 2026, Fabtech Technologies had annual revenue of 4.11B with 25.75% growth. That makes Fabtech Technologies the 28,813th largest company in the world by revenue and 1,943rd in India.
Revenue (ttm)
4.18B
Revenue Growth
+14.16%
P/S Ratio
1.44
Revenue / Employee
22.46M
Employees
186
Market Cap
6.03B
Revenue by Geography
- Rest of The World 859.69M 20.9%
- UAE 829.92M 20.2%
- Saudi Arabia 827.24M 20.1%
- India 453.31M 11.0%
- Kenya 434.22M 10.6%
- Morocco 220.10M 5.4%
- Iraq 195.34M 4.8%
- Other 287.91M 7.0%
Fiscal year ended Mar 31, 2026 See the full Fabtech Technologies breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.11B | 841.03M | 25.75% |
| Mar 31, 2025 | 3.27B | 1.01B | 44.46% |
| Mar 31, 2024 | 2.26B | 323.39M | 16.69% |
| Mar 31, 2023 | 1.94B | -633.82M | -24.65% |
| Mar 31, 2022 | 2.57B | 1.36B | 112.49% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Divi's Laboratories | 121.91B |
| Lenskart Solutions | 103.83B |
| Laurus Labs | 78.23B |
| Health X Platform | 15.13B |
| Valiant Laboratories | 3.76B |
| Amanta Healthcare | 3.04B |
| Max India | 2.84B |